The 2nd factor is the price. As we have reported, there is only one medicine now currently being marketed in Portugal with the price of EUR 475.27. Despite having co-payment at the rate of 37%, the affected person still has got to bear a substantial A part of the cost, that makes the use of therapy tough to a significant proportion of sufferers.___